Drug provision for ischemic heart disease and arterial hypertension in the Republic of Tajikistan

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. The increase in the incidence of coronary heart disease (CHD) and arterial hypertension (AH) in the Republic of Tajikistan, as well as the lack of social programs for drug provision, highlight the need to study the views of doctors regarding the prescription of drugs.

Objective. To study the preferences and opinions of physicians regarding drug provision for coronary heart disease and arterial hypertension in the Republic of Tajikistan to identify ways to optimize and improve pharmaceutical care for these patients.

Material and methods. The source for the research work were questionnaires of doctors of the Republican Clinical Center of Cardiology of the Republic of Tajikistan of all departments, the department of cardiorheumatology of the City Clinical Hospital No. 2 named after K. Tadjiev in Dushanbe, the National Diagnostic Center of the Republic of Tajikistan and City Health Centers No.1, 8, 10, 14, Dushanbe.

The work uses methods of content analysis, systematization, generalization, descriptive statistics using the program MS Office Excel 2017".

Results. 64% of physicians prefer fixed combinations or their combination with monotherapy. In 69% of cases, the choice of drug is influenced by the patient's ability to pay. Physicians generally follow clinical protocols, but only 52% systematically comply with them. An assessment of the availability of the latest drugs showed that almost half of physicians have only partial access to them. Most physicians have a positive attitude towards involving pharmacy workers in a multidisciplinary team of healthcare professionals in providing services to patients with coronary heart disease and hypertension.

Conclusion. Fixed combinations are considered more effective, especially by younger and middle-aged cardiologists. Doctors choose drugs mainly without reference to the manufacturer, focusing on effectiveness. The patient's solvency is an important criterion when prescribing therapy. The physician respondents acknowledge the importance of interprofessional interaction with pharmacists, in particular in terms of polypharmacy, consultation and coordination of actions. The obtained results can be used to improve pharmaceutical care and expand the functionality of pharmacists within the team model of care.

全文:

受限制的访问

作者简介

Muhabbat Saidova

Tajik National University

编辑信件的主要联系方式.
Email: sald_mouhabbat@mail.ru
ORCID iD: 0009-0000-4181-0155
SPIN 代码: 6044-8926

Candidate of Pharmaceutical Sciences, Associate Professor of the Department of Pharmaceutical Chemistry and Management of Pharmacy Economics

塔吉克斯坦, Rudaki Avenue, 17, Dushanbe, 734025

参考

  1. World Health Rankings. Live longer live better. Tajikistan Top-50 causes of death/ Age-Standardized death rate. Per 100,000 Population. 2025. [Electronic resource] URL: https://www.worldlifeexpectancy.com/country-health-profile/tajikistan (in Engl)
  2. Постановление Правительства Республики Таджикистан от 30.06.2007 № 334 «Национальная программа профилактики, диагностики и лечения ишемической болезни сердца на период 2007–2015 гг.». [Resolution of the Government of the Republic of Tajikistan dated June 30, 2007 No. 334 “National program for the prevention, diagnosis and treatment of ischemic heart disease for the period 2007–2015.”] [Electronic resource] URL: http://portali-huquqi.tj/publicadliya/view_qonunhoview.php?showdetail=&asosi_id=9261 (In Russian)].
  3. Выявление путей улучшения оказания медицинских услуг по лечению артериальной гипертензии в Республике Таджикистан. The World Bank: 2019. Электронный ресурс. Identifying ways to improve the provision of medical services for the treatment of arterial hypertension in the Republic of Tajikistan. The World Bank: 2019. [Electronic resource] URL:https://documents1.worldbank.org/curated/pt/241421570549897683/pdf/Identifying-Opportunities-to-Strengthen-Service-Delivery-для-Hypertension-in -Tajikistan.pdf (In Russian)].
  4. Саидова М.Н. Предпосылки усовершенствования фармацевтической составляющей медицинской помощи пациентам с сердечно-сосудистыми заболеваниями в Республике Таджикистан. Медицинский вестник Башкортостана. 2025; 1. [Saidova M.N. Prerequisites for improving the pharmaceutical component of medical care for patients with cardiovascular diseases in the Republic of Tajikistan. Medical Bulletin of Bashkortostan. 2025; 1 (In Russian)].
  5. Serge C. Harb, Paul C. Cremer, Yuping Wu. Bo Xu, Leslie Cho, Venu Menon, Wael A Jaber, Estimated age based on exercise stress testing performance outperforms chronological age in predicting mortality, Eur. J. of Preventive Cardiology. 2021; 28 (12): 1295–302. https://doi.org/10.1177/2047487319826400
  6. Jain P., & Jha S.C. Combination therapy for hypertension management: insights from the Indian experts. Int. J. of Scientific Reports. 2024; 10 (6): 200–5. https://doi.org/10.18203/issn.2454-2156.IntJSciRep20241317
  7. Luo, X., Liu, W., Sun, N., Bo, P., Chen, Y., Han, Q., Li, N., Lu, X., Mou, J., Sun, G., & Zhang, Y. The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population-based cross-sectional study. J. of clin. hypertension (Greenwich, Conn.). 2024; 26 (9): 1054–62. https://doi.org/10.1111/jch.14870
  8. Whitelaw S., Pellegrini D.M., Mamas M.A., Cowie M., & Van Spall H.G.C. Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review. Eur. heart J. Digital health. 2021; 2 (1): 62–74. https://doi.org/10.1093/ehjdh/ztab005
  9. Nichol C., Das R., Barry G., Kelly M., Vogiatzis I., & Adams N. A Qualitative Study of Barriers and Facilitators to the Uptake of Cardiac Rehabilitation in Octogenarians. Geriatrics. 2024; 9 (6): 161. https://doi.org/10.3390/geriatrics9060161
  10. Саидова М.Н., Гулов Э.С. Трендовый анализ фармацевтического рынка сердечно-сосудистых препаратов В Республики Таджикистан. Наука и Инновация, г. Душанбе. 2024; 1: 35–41. [Saidova M.N., Gulov E.S. Trend analysis of the pharmaceutical market of cardiovascular drugs in the Republic of Tajikistan. Science and Innovation, Dushanbe. 2024; 1: 35–41 (In Russian)].

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Diagram of doctors’ preferences in choosing drugs

下载 (63KB)
索引源数据
3. Fig. 2. Diagram of doctors’ preferences depending on gender and specialization

下载 (91KB)
索引源数据
4. Fig. 3. Diagram of physicians’ preferences when choosing original and generic drugs for patients with hypertension and СHD

下载 (56KB)
索引源数据
5. Fig. 4. Diagram of distribution of doctors’ opinions regarding the reasons for ineffective blood pressure control in patients with coronary heart disease and hypertension

下载 (100KB)
索引源数据
6. Fig. 5. Results of the opinion of doctors in solving the problems of patients with hypertension from the pharmacists’ side

下载 (479KB)
索引源数据

版权所有 © Russkiy Vrach Publishing House, 2025